NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Biobeat

Biobeat

Private
IsraelHealthcare & Life Scienceshttps://www.bio-beat.com/

Last Round

Series B

Dec 30, 2025

Total Funding Raised

$58M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Biobeat is a medical technology company that develops wearable remote patient monitoring devices designed to measure vital signs using wireless, non-invasive, and medical-grade technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Telemedicine, Healthcare Analytics, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

remote patient monitoringRPMwearable medical devicecuffless blood pressurevital sign monitoringdigital healthtelemedicineclinical analyticshealth IoTcontinuous monitoringvirtual wardhospital at homeelectronic medical recordsEMRclinical decision supportwearable sensormHealth

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biobeat Comparables

Compare Biobeat with similar companies based on industry and business-model similarity.

Biobeat comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioIntelliSense
91%
VitalConnect
84%
Vivalink
83%

Biobeat Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BDec 30, 2025
Series AMar 1, 2020

Key People

Founding team and executive leadership

Johanan May

Co-Founder And Chief Technology Officer

Founding Team

Arik B.

Co-Founder And CEO

Founding Team

Ran Zafir

Chief Financial Officer

Executive Team

Biobeat Investors

Notable investors and investment history

Biobeat investors
InvestorRounds
Ally Bridge GroupSeries B
OrbiMedSeries B
Menomadin FoundationSeries A
Elevage Medical TechnologiesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    First-of-its-kind cuffless 24-hour blood pressure monitoring system cleared by FDA.

  • Dec 30, 2025

    $50M round completed.

Biobeat Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Biobeat Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biobeat's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range77
Year Founded2014
Last FundingDec 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.